Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Rai

Showing results (431-440 of 543) with videos related to

Pageof 55
Sort By:
Annals of Medicine and Surgery (2012)|April 28, 2023
The presentation delay and differences of symptoms manifestation in Myocardial Infarction patients with and without Diabetes: a cross-sectional studyRaveena, Syed Z A Naqvi, Sangam, et al.
Haematologica|December 22, 2010
Subcutaneous injections of low-dose veltuzumab (humanized anti-CD20 antibody) are safe and active in patients with indolent non-Hodgkin's lymphomaGeorge O Negrea, Rebecca Elstrom, Steven L Allen, et al.
Physics in Medicine and Biology|May 26, 2018
Imaging performance of a dedicated radiation transparent RF coil on a 1.0 Tesla inline MRI-linacG P Liney, B Dong, E Weber, et al.
The Journal of Experimental Medicine|September 5, 2002
Chronic lymphocytic leukemia B cells can undergo somatic hypermutation and intraclonal immunoglobulin V(H)DJ(H) gene diversificationCarmela Gurrieri, Peter McGuire, Hong Zan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2011
Chemoimmunotherapy with fludarabine and rituximab produces extended overall survival and progression-free survival in chronic lymphocytic leukemia: long-term follow-up of CALGB study 9712Jennifer A Woyach, Amy S Ruppert, Nyla A Heerema, et al.
Blood|January 25, 2008
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelinesMichael Hallek, Bruce D Cheson, Daniel Catovsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2002
Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011Vicki A Morrison, Kanti R Rai, Bercedis L Peterson, et al.
Frontiers in Immunology|March 26, 2021
A Detailed Analysis of Parameters Supporting the Engraftment and Growth of Chronic Lymphocytic Leukemia Cells in Immune-Deficient MicePiers E M Patten, Gerardo Ferrer, Shih-Shih Chen, et al.
Blood|September 14, 2011
Identification of outcome-correlated cytokine clusters in chronic lymphocytic leukemiaXiao-Jie Yan, Igor Dozmorov, Wentian Li, et al.
Molecular Medicine (Cambridge, Mass.)|January 19, 2017
Binding of CLL subset 4 B-cell receptor immunoglobulins to viable human memory B lymphocytes requires a distinctive IGKV somatic mutationRosa Catera, Yun Liu, Chao Gao, et al.
Pageof 55

Showing results (431-440 of 543) with videos related to

Sort By:
Pageof 55
Annals of Medicine and Surgery (2012)|April 28, 2023
The presentation delay and differences of symptoms manifestation in Myocardial Infarction patients with and without Diabetes: a cross-sectional studyRaveena, Syed Z A Naqvi, Sangam, et al.
Haematologica|December 22, 2010
Subcutaneous injections of low-dose veltuzumab (humanized anti-CD20 antibody) are safe and active in patients with indolent non-Hodgkin's lymphomaGeorge O Negrea, Rebecca Elstrom, Steven L Allen, et al.
Physics in Medicine and Biology|May 26, 2018
Imaging performance of a dedicated radiation transparent RF coil on a 1.0 Tesla inline MRI-linacG P Liney, B Dong, E Weber, et al.
The Journal of Experimental Medicine|September 5, 2002
Chronic lymphocytic leukemia B cells can undergo somatic hypermutation and intraclonal immunoglobulin V(H)DJ(H) gene diversificationCarmela Gurrieri, Peter McGuire, Hong Zan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2011
Chemoimmunotherapy with fludarabine and rituximab produces extended overall survival and progression-free survival in chronic lymphocytic leukemia: long-term follow-up of CALGB study 9712Jennifer A Woyach, Amy S Ruppert, Nyla A Heerema, et al.
Blood|January 25, 2008
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelinesMichael Hallek, Bruce D Cheson, Daniel Catovsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2002
Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011Vicki A Morrison, Kanti R Rai, Bercedis L Peterson, et al.
Frontiers in Immunology|March 26, 2021
A Detailed Analysis of Parameters Supporting the Engraftment and Growth of Chronic Lymphocytic Leukemia Cells in Immune-Deficient MicePiers E M Patten, Gerardo Ferrer, Shih-Shih Chen, et al.
Blood|September 14, 2011
Identification of outcome-correlated cytokine clusters in chronic lymphocytic leukemiaXiao-Jie Yan, Igor Dozmorov, Wentian Li, et al.
Molecular Medicine (Cambridge, Mass.)|January 19, 2017
Binding of CLL subset 4 B-cell receptor immunoglobulins to viable human memory B lymphocytes requires a distinctive IGKV somatic mutationRosa Catera, Yun Liu, Chao Gao, et al.
Pageof 55